Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
To evaluate the effectiveness of erythropoietin (EPO) administration as a treatment for anemia, especially related to chemotherapy and kidney disease.
Serum collected in a gold-, red-, or red/gray-top tube.
(Method: Immunochemiluminometric assay)
|Age||Conventional & SI Units||Conventional & SI Units|
|0–3 yr||1.7–17.9 milli-international units/mL||2.1–15.9 milli-international units/mL|
|4–6 yr||3.5–21.9 milli-international units/mL||2.9–8.5 milli-international units/mL|
|7–9 yr||1.1–13.5 milli-international units/mL||2.1–8.2 milli-international units/mL|
|10–12 yr||1.1–14.1 milli-international units/mL||1.1–9.1 milli-international units/mL|
|13–15 yr||2.2–14.4 milli-international units/mL||3.8–20.5 milli-international units/mL|
|16–18 yr||1.5–15.2 milli-international units/mL||2.1–14.2 milli-international units/mL|
|Adult||4.2–27.8 milli-international units/mL||4.2–27.8 milli-international units/mL|
|Based on normal hemoglobin and hematocrit. Values may be decreased in older adults due to the effects of medications and the presence of multiple chronic or acute diseases with or without muted symptoms.|